FDA clearance for new OCULUS Pentacam


Colin Kerr
Published: Tuesday, March 1, 2016
[caption id="attachment_6788" align="alignnone" width="750"]
OCULUS Pentacam AXL
Pentacam neu mit Achlängenmessung, Weltpremiere zur ESCRS 2015 in Barcelona.[/caption] FDA CLEARANCE The new OCULUS Pentacam® AXL has received the 510(k) clearance of the US Food and Drug Administration (FDA). “The Pentacam® AXL represents the systematic further development of the successful and time-proven Pentacam® HR. The intuitive and network-compatible intraocular lens (IOL) calculation software offers solutions to nearly every challenge,” said a company spokeswoman. “Standard formulas, such as formulas for treated corneas, for toric IOLs, and ray-tracing formulas, are already integrated. The calculation of toric IOLs is based on the total corneal refractive power (TCRP), thus taking the influence of the posterior corneal surface into account. A comprehensive IOL database with IOL constants for the Pentacam® AXL is also integrated,” she added. www.pentacam.com NEW RECORD AT USER MEETING There was a new record participation at the SCHWIND User Meeting, said a company spokeswoman. “Two-hundred and thirty users from 40 different countries came together from 21-24 January in Singapore to hear professional lectures and to exchange their experiences with SCHWIND technologies,” said the spokeswoman. The SCHWIND User Meeting takes place on a different continent every year and the choice of Singapore as this year’s event location was SCHWIND eye-tech-solutions’ answer to the ever-growing number of participants and the high demand for SCHWIND technologies in Asia. www.eye-tech-solutions.com BETTER OPTICS Katena Products has announced the acquisition of Sensor Medical Technology (SMT). SMT specialises in the development and manufacture of high-quality single-use and reusable diagnostic and therapeutic lenses used by ophthalmologists and optometrists in the USA and globally. “The acquisition of SMT is an important addition to Katena’s product portfolio. SMT disposable and reusable lenses represent an improvement to current clinical practice, as it relates to consistently better optics, while eliminating the chance of disease transmission,” said Bill Friedberg, CEO of Katena Products. www.katena.com IT SOLUTION Topcon has acquired 50.1 per cent of the shares of ifa systems AG. Ifa develops, markets, and provides consulting services for health IT solutions in the eye care field, and sells electronic medical record systems connectable to various types of ophthalmic examination devices. “By acquiring more than half of the outstanding common shares and majority rights, Topcon will integrate ifa’s health IT solution into its eye care business unit and accelerate its growth strategy,” said a spokesman. “With the rapid aging of the world’s population as well as explosive population growth, operational efficiency in eye care clinical practice and financial efficiency are key requirements for today’s ophthalmic practice,” he added. www.topcon.co.jp/en www.ifasystems.com DIGITAL MEDICAL SCOPE Nidek has launched the Digital Medical Scope VersaCam™ α. “The VersaCam, α versatile and portable fundus imaging unit, provides high-quality images with simple functionality,” said a company spokesman. “The lightweight and compact design allow easy portability from room to room or centre to centre, enhancing patient convenience. This portable unit with intuitive user functionality means fundus screenings can be performed virtually anywhere regardless of whether the patient is sitting or supine,” added the spokesman. www.nidek-intl.com/product/ophthaloptom/diagnostic/dia_retina/ds-20f.html

Pentacam neu mit Achlängenmessung, Weltpremiere zur ESCRS 2015 in Barcelona.[/caption] FDA CLEARANCE The new OCULUS Pentacam® AXL has received the 510(k) clearance of the US Food and Drug Administration (FDA). “The Pentacam® AXL represents the systematic further development of the successful and time-proven Pentacam® HR. The intuitive and network-compatible intraocular lens (IOL) calculation software offers solutions to nearly every challenge,” said a company spokeswoman. “Standard formulas, such as formulas for treated corneas, for toric IOLs, and ray-tracing formulas, are already integrated. The calculation of toric IOLs is based on the total corneal refractive power (TCRP), thus taking the influence of the posterior corneal surface into account. A comprehensive IOL database with IOL constants for the Pentacam® AXL is also integrated,” she added. www.pentacam.com NEW RECORD AT USER MEETING There was a new record participation at the SCHWIND User Meeting, said a company spokeswoman. “Two-hundred and thirty users from 40 different countries came together from 21-24 January in Singapore to hear professional lectures and to exchange their experiences with SCHWIND technologies,” said the spokeswoman. The SCHWIND User Meeting takes place on a different continent every year and the choice of Singapore as this year’s event location was SCHWIND eye-tech-solutions’ answer to the ever-growing number of participants and the high demand for SCHWIND technologies in Asia. www.eye-tech-solutions.com BETTER OPTICS Katena Products has announced the acquisition of Sensor Medical Technology (SMT). SMT specialises in the development and manufacture of high-quality single-use and reusable diagnostic and therapeutic lenses used by ophthalmologists and optometrists in the USA and globally. “The acquisition of SMT is an important addition to Katena’s product portfolio. SMT disposable and reusable lenses represent an improvement to current clinical practice, as it relates to consistently better optics, while eliminating the chance of disease transmission,” said Bill Friedberg, CEO of Katena Products. www.katena.com IT SOLUTION Topcon has acquired 50.1 per cent of the shares of ifa systems AG. Ifa develops, markets, and provides consulting services for health IT solutions in the eye care field, and sells electronic medical record systems connectable to various types of ophthalmic examination devices. “By acquiring more than half of the outstanding common shares and majority rights, Topcon will integrate ifa’s health IT solution into its eye care business unit and accelerate its growth strategy,” said a spokesman. “With the rapid aging of the world’s population as well as explosive population growth, operational efficiency in eye care clinical practice and financial efficiency are key requirements for today’s ophthalmic practice,” he added. www.topcon.co.jp/en www.ifasystems.com DIGITAL MEDICAL SCOPE Nidek has launched the Digital Medical Scope VersaCam™ α. “The VersaCam, α versatile and portable fundus imaging unit, provides high-quality images with simple functionality,” said a company spokesman. “The lightweight and compact design allow easy portability from room to room or centre to centre, enhancing patient convenience. This portable unit with intuitive user functionality means fundus screenings can be performed virtually anywhere regardless of whether the patient is sitting or supine,” added the spokesman. www.nidek-intl.com/product/ophthaloptom/diagnostic/dia_retina/ds-20f.html
Latest Articles
Making Female Leadership More than a Moment
A remarkable global confluence of women in key positions.
ESCRS Talks Technology at AAO
Europe adopts technological advances, US still waiting for lenses and lasers.
Sorting Out Simultaneous Vision IOLs
The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.
Big Advantages to Small-Aperture IOLs
Small-aperture IOLs offer superior image quality with increased range of focus.
Prioritising Self-Care
Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.
Valuing Clinical Trial Design
How inclusivity and diversity can enhance scientific accuracy in research.
Knowing Iris Repair: Using Iridodiathermy in Iris Surgery
Prepare for decentred pupils and uneven irides in multiple situations.
Neuroprotectant Treatment for MacTel Type 2
Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.